ESTRELLA IMMUNOPHARMA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ESTRELLA IMMUNOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $12.72K, a 2323.81% increase year-over-year.
- ESTRELLA IMMUNOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $525.00.
- ESTRELLA IMMUNOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $525.00.
- ESTRELLA IMMUNOPHARMA, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $525.00.
- ESTRELLA IMMUNOPHARMA, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $12.72K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-06-30 | $12.72K 10-KT · filed 2025-03-25 | |
| 2023-09-30 | $12.72K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $525.00 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $525.00 10-Q · filed 2024-05-15 | |
| 2022-09-30 | $525.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |